AU2006244401B2 - Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents - Google Patents

Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents Download PDF

Info

Publication number
AU2006244401B2
AU2006244401B2 AU2006244401A AU2006244401A AU2006244401B2 AU 2006244401 B2 AU2006244401 B2 AU 2006244401B2 AU 2006244401 A AU2006244401 A AU 2006244401A AU 2006244401 A AU2006244401 A AU 2006244401A AU 2006244401 B2 AU2006244401 B2 AU 2006244401B2
Authority
AU
Australia
Prior art keywords
als
candida
mice
protein
albicans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006244401A
Other languages
English (en)
Other versions
AU2006244401A1 (en
AU2006244401A8 (en
Inventor
John E. Edwards Jr.
Scott G. Filler
Yue Fu
Ashraf Ibrahim
Donald C. Sheppard
Brad J. Spellberg
Michael Yeaman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Original Assignee
Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center filed Critical Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Publication of AU2006244401A1 publication Critical patent/AU2006244401A1/en
Publication of AU2006244401A8 publication Critical patent/AU2006244401A8/en
Priority to AU2012216520A priority Critical patent/AU2012216520A1/en
Application granted granted Critical
Publication of AU2006244401B2 publication Critical patent/AU2006244401B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2006244401A 2005-05-05 2006-05-04 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents Ceased AU2006244401B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012216520A AU2012216520A1 (en) 2005-05-05 2012-08-23 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/123,873 US20060083750A1 (en) 1999-11-19 2005-05-05 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
US11/123,873 2005-05-05
PCT/US2006/017482 WO2006121895A2 (en) 2005-05-05 2006-05-04 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012216520A Division AU2012216520A1 (en) 2005-05-05 2012-08-23 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

Publications (3)

Publication Number Publication Date
AU2006244401A1 AU2006244401A1 (en) 2006-11-16
AU2006244401A8 AU2006244401A8 (en) 2006-11-16
AU2006244401B2 true AU2006244401B2 (en) 2012-09-06

Family

ID=37397150

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006244401A Ceased AU2006244401B2 (en) 2005-05-05 2006-05-04 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

Country Status (6)

Country Link
US (1) US20060083750A1 (enExample)
EP (1) EP1883421A4 (enExample)
JP (1) JP2008540453A (enExample)
AU (1) AU2006244401B2 (enExample)
CA (1) CA2607176A1 (enExample)
WO (1) WO2006121895A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) * 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
RU2015122387A (ru) * 2009-07-03 2015-10-27 Лос-Анжелес Биомедикал Ресёрч Институт Эт Харбор-Укла Медикал Центер Hyr1 в качестве мишени для активной и пассивной иммунизации против candida
CA2871081A1 (en) * 2011-04-21 2012-10-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Peptide and conjugate vaccines for fungal infections
CN103998056B (zh) * 2011-07-22 2017-09-12 诺瓦蒂格姆疗法有限公司 用于接种抗金黄色葡萄球菌疫苗的方法和组合物
EA030005B1 (ru) 2013-03-15 2018-06-29 Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер Композиции и способы лечения грибковых и бактериальных патогенов
CN108883167A (zh) 2016-03-09 2018-11-23 加州大学洛杉矶分校港口医学中心生物医学研究所 用于预防和治疗外阴阴道念珠菌病的方法和药剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124134A1 (en) * 1999-11-19 2003-07-03 Harbor-Ucla Research And Education Institute Pharmaceutical compositions and methods to vaccinate against candidiasis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US5668263A (en) * 1994-12-16 1997-09-16 Smithkline Beecham Corporation Conserved yeast nucleic acid sequences
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US7067138B1 (en) * 1999-11-19 2006-06-27 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
US20070077256A1 (en) * 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
CA2325774C (en) * 1999-12-10 2011-02-08 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Coniothyrium minitans .beta.-(1,3) exoglucanase gene cbeg1
US7241613B1 (en) * 2002-06-05 2007-07-10 Oscient Pharmaceuticals Corporation Identification of Candida cell surface proteins and their uses
UA109105C2 (uk) * 2006-04-17 2015-07-27 Молекула нуклеїнової кислоти, що кодує істотно нетоксичний мутеїн альфа-токсину clostridium perfringens, та істотно нетоксичний мутеїн альфа-токсину clostridium perfringens

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124134A1 (en) * 1999-11-19 2003-07-03 Harbor-Ucla Research And Education Institute Pharmaceutical compositions and methods to vaccinate against candidiasis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ibrahim, A. et al. INFECTION AND IMMUNITY, Feb. 2005, Vol. 73, No. 2, p. 999-1005 *

Also Published As

Publication number Publication date
WO2006121895A2 (en) 2006-11-16
AU2006244401A1 (en) 2006-11-16
JP2008540453A (ja) 2008-11-20
EP1883421A2 (en) 2008-02-06
US20060083750A1 (en) 2006-04-20
AU2006244401A8 (en) 2006-11-16
EP1883421A4 (en) 2009-12-16
CA2607176A1 (en) 2006-11-16
WO2006121895A3 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
US10300120B2 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
Wang et al. Vaccines in the treatment of invasive candidiasis
US20140127217A1 (en) Pharmaceutical compositions and methods to vaccinate against candidiasis
Sui et al. The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections
EP2448959B1 (en) Hyr1 as a target for active and passive immunization against candida
WO1998009990A1 (en) Fungal antigens and process for producing the same
AU2006244401B2 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US7067138B1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
AU2012216520A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
AU2013203750A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
Chandley et al. Role of Vaccines and Monoclonal Antibodies in Systemic Candidiasis: Past and Future Approaches
JPH10234379A (ja) 真菌抗原及びその製造方法
Ito 34 Vaccine Development against Fungi

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 21, NO 50, PAGE(S) 5753 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER, APPLICATION NO. 2006244401, UNDER INID (71), CORRECT THE APPLICANT NAME TO LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR- UCLA MEDICAL CENTER.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired